KCNK9 Antikörper (AA 265-374)
Kurzübersicht für KCNK9 Antikörper (AA 265-374) (ABIN6142756)
Target
Alle KCNK9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 265-374
-
Sequenz
- AGNRNSMVIH IPEEPRPSRP RYKADVPDLQ SVCSCTCYRS QDYGGRSVAP QNSFSAKLAP HYFHSISYKI EEISPSTLKN SLFPSPISSI SPGLHSFTDH QRLMKRRKSV
-
Kreuzreaktivität
- Human, Maus
-
Produktmerkmale
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 265-374 of human KCNK9 (NP_001269463.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Kommentare
-
HIGH QUALITY
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- KCNK9 (Potassium Channel, Subfamily K, Member 9 (KCNK9))
-
Andere Bezeichnung
- KCNK9
-
Hintergrund
- This gene encodes a protein that contains multiple transmembrane regions and two pore-forming P domains and functions as a pH -dependent potassium channel. Amplification and overexpression of this gene have been observed in several types of human carcinomas. This gene is imprinted in the brain, with preferential expression from the maternal allele. A mutation in this gene was associated with Birk-Barel mental retardation dysmorphism syndrome. Alternative splicing results in multiple transcript variants.,KCNK9,K2p9.1,KT3.2,TASK-3,TASK3,Cancer,Neuroscience,KCNK9
-
Molekulargewicht
- 42 kDa
-
Gen-ID
- 51305
-
UniProt
- Q9NPC2
Target
-